A retrospective study to evaluate the correlation of Endothelial Activation and Stress Index (EASIX) to CAR T cell related Cytokine release syndrome (CRS) and immune effector cell-associated neurotoxicity syndrome (ICANS)
Latest Information Update: 12 Jan 2021
At a glance
- Drugs Axicabtagene ciloleucel (Primary)
- Indications Diffuse large B cell lymphoma; Follicular lymphoma; Mediastinal disorders; Non-Hodgkin's lymphoma
- Focus Adverse reactions
- 12 Jan 2021 New trial record
- 08 Dec 2020 Results presented at the 62nd Annual Meeting and Exposition of the American Society of Hematology